
Who's online
There are currently 8 users and 259 guests online.
Online users
- patrick sampao
- Sysadmin
- nicoM
- Inga
- MUTOMBO MULANGU A...
- nick golding
- Kabogo
- Moon
News Flash
Recent blog posts
- Where the real battle is won
- Amazing statements by leading malariologists
- How was malaria of 100 years ago eradicated in Palestine/Israel? And without vaccine?
- Winston Hide's courageous move
- Event: Symposium Malaria, maternal and infant health
- Job: Senior Lecturer / Lecturer in Epidemiology
- Job: Inspiring scientists in infectious tropical diseases
- Can we maintain effectiveness of the tools?
- Advertising on MalariaWorld
- Malaria elimination country briefings published by the UCSF Global Health Group
Active forum topics
- The role of community education and involvement in malaria control
- Introduce yourself to MalariaWorld members
- Fighting drug resistance by switching to environmental management of mosquito habitats
- Need for additional group to supplement WHO in fight against malaria
- Sustainable additions to WHO and PMI strategy
New forum topics
- Fighting drug resistance by switching to environmental management of mosquito habitats
- Grand Challemges Canada round 2. Help fund a malaria related project!
- Open Access 2.0:How to achieve this
- Pouring gasoline on the insecticide resistance fire?
- Need for additional group to supplement WHO in fight against malaria
Deadline for applications: February 13, 2012 (position open until filled)
Position ID: FY2011-84.IDG
The La Jolla Bioengineering Institute invites applications for a post-doctoral position in malaria research using the Plasmodium berghei ANKA mouse model of cerebral malaria (CM).
This week a 31 year-old woman living in Jacksonville, Florida, got infected with the most deadly form of malaria, Plasmodium falciparum. Just weeks ago a similar report came from Spain, where indigenous transmission occurred and led to the first case of malaria since 1961.
CDC received reports of 1,298 cases of malaria with an onset of symptoms in 2008 among patients in the United States, a decrease of 13.8% from the 1,505 cases reported for 2007 (p<0.001). These cases included one transfusion-related case, one congenital case, and two fatal cases. Plasmodium falciparum, P. vivax, P. malariae, and P. ovale were identified in 40.6%, 14.6%, 1.5%, and 1.4% of cases, respectively.